This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: National University of Singapore, Dso National Laboratories, Agency for Science, Technology and Research. Active years: 2016-2019.
Company Filing History:
4 out of 850 
3 out of 14 
2 out of 1,556 
Years Active: 2016-2019
Title: The Innovative Contributions of Paul Macary
Introduction
Paul Macary is a notable inventor based in Singapore, known for his significant contributions to the field of biomedical research. With a total of five patents to his name, he has made strides in developing treatments for dengue virus infections. His work is characterized by a focus on antibody development and therapeutic applications.
Latest Patents
Among his latest patents is the invention titled "Serotype cross-reactive, dengue neutralizing antibody and uses thereof." This patent discloses isolated antibodies that bind to dengue virus epitopes, along with kits and compositions that utilize these antibodies. The invention emphasizes the capability of these antibodies to bind more effectively to whole dengue virus particles compared to surface glycoproteins. Another significant patent is for a "Human monoclonal antibody with specificity for dengue virus serotype 1 E protein and uses thereof." This patent outlines methods for treating or preventing dengue virus infections in vertebrate subjects using human neutralizing monoclonal antibodies isolated from patients who have recovered from dengue.
Career Highlights
Paul Macary has worked with prestigious institutions such as the National University of Singapore and DSO National Laboratories. His career is marked by a commitment to advancing medical science through innovative research and development.
Collaborations
Throughout his career, Paul has collaborated with notable colleagues, including Brendon John Hanson and Ee Ping Evelyn Teoh. These collaborations have contributed to the success of his research endeavors and the development of his patents.
Conclusion
Paul Macary's work exemplifies the impact of innovative research in combating infectious diseases. His patents and collaborations highlight his dedication to improving public health through scientific advancements.